- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
|Professor Vladimir Torchilin|
In a fascinating keynote presentation at Nanomedicine 2010: Visions for the Future, Professor Vladimir Torchilin shows how nanotechnology is being applied to make novel multifunctional pharmaceutical nanocarriers to meet some of these major challenges to delivering modern advanced pharmaceuticals safely and efficiently.
Multifunctional pharmaceutical nanocarriers
Carriers are needed for a number of reasons in drug delivery, e.g. to protect the drug from the body, to protect the body from the drug and to adjust the pharmacokinetics, i.e. distribution and clearance, of the drug. In addition it is also necessary to use approved components, to make the preparation process simple and scalable, to make a reproducible product with easy to control properties and to make the product economically.
Vladimir P. Torchilin, PhD, DSc is Distinguished Professor of Pharmaceutical Sciences and Director, Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston, Massachusetts. He graduated from Moscow University and also obtained his PhD and DSc there in polymer chemistry, chemical kinetics and catalysis, and chemistry of physiologically active compounds. In 1991 he joined Massachusetts General Hospital and Harvard Medical School as the Head of the Chemistry Program and Associate Professor of Radiology. Since 1998 Dr. Torchilin has been with Northeastern University where he was Chair of the Department of Pharmaceutical Sciences from1998-2008. His research interests have focused on biomedical polymers, polymeric drugs, immobilized medicinal enzymes, drug delivery and targeting, pharmaceutical nanocarriers for diagnostic and therapeutic agents, and experimental cancer immunology. He has published more than 300 original papers, more than 100 reviews and book chapters, has written and edited10 books, and holds more that 40 patents.
To register for Nanomedicine 2010: Visions for the Future, visit:
About The Institute of Nanotechnology
The Institute of Nanotechnology (IoN) was founded by Ottilia Saxl in January 1997. It is a registered Charity, whose core activities are focused on education and training in nanotechnology, in the widest sense. It grew out of the Centre for Nanotechnology, part funded by the DTI through the UK 's National Initiative on Nanotechnology (NION). The Institute was one of the world's first nanotechnology information providers and is now a global leader.
IoN works closely with governments, universities, researchers, companies and the general public to educate and inform on all aspects of nanotechnology. It is also an organizer of international scientific events, conferences and educational courses that examine the implications of nanotechnology for industry, society, health, energy and the environment, and the disadvantaged communities across the globe.
For more information, please click here
Manager, Conferences and Events
Institute of Nanotechnology
t: +44 (0)141 303 8444 ext.110
f: +44 (0)141 552 7499
Copyright © The Institute of NanotechnologyIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Richards-Kortum elected to American Academy of Arts and Sciences: April 22nd, 2015
Harris & Harris Group Sponsors NYC American Heart Association's Health Sciences Innovation Investment Forum: Co-founder of Harris & Harris Group Portfolio Company TARA Biosystems to Speak About the Value of Tissue Engineering Technology April 21st, 2015
Long Island Capital Alliance Announces Participants for Brookhaven National Laboratory Technology Transfer Capital Forum on May 8: Keynote Speaker Dr. Doon Gibbs, Director of Brookhaven National Laboratory April 16th, 2015
Rafts on the cell membrane: Researchers from TU Wien (Vienna) shed light on a big secret of cell membranes: The 'lipid rafts', which have been believed to move within the cell membrane, do not really exist April 21st, 2015